tiprankstipranks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14)
:T14
Singapore Market
T14
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
RESEARCH TOOLSreports

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Income Statement

Compare
5 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Income Statement

Last quarter (Q3 2024), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was ¥1.65B, a decrease of -3.43% from the same quarter last year. In Q3, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was ¥146.14M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 8.22B¥ 8.25B¥ 6.91B¥ 6.60B¥ 6.99B
Gross Profit
¥ 3.62B¥ 3.29B¥ 2.76B¥ 2.58B¥ 2.95B
Operating Expenses
¥ 2.52B¥ 2.57B¥ 2.14B¥ 1.98B¥ 2.38B
Depreciation and Amortization
¥ 130.13M¥ 116.56M¥ 115.53M¥ 110.85M¥ 98.15M
EBITDA
¥ 1.26B¥ 1.11B¥ 991.28M¥ 878.91M¥ 846.19M
Operating Income
¥ 1.10B¥ 980.05M¥ 866.68M¥ 785.18M¥ 759.02M
Other Income/Expenses
¥ -1.61M¥ 138.80K¥ 6.13M¥ -17.12M¥ -15.88M
Pretax Income
¥ 1.10B¥ 980.19M¥ 872.81M¥ 768.06M¥ 743.15M
Net Income
¥ 986.71M¥ 861.79M¥ 769.14M¥ 661.70M¥ 625.57M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 1.28¥ 1.12¥ 1.00¥ 0.86¥ 0.81
Diluted EPS
¥ 1.28¥ 1.11¥ 1.00¥ 0.86¥ 0.81
Weighted Average Shares Outstanding
770.87M 769.46M 768.87M 768.87M 768.87M
Weighted Average Shares Outstanding (Diluted)
770.87M 776.39M 769.14M 769.42M 772.31M
Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis